Navigation Links
Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS)
Date:5/20/2013

aking this non-stimulant potential treatment for ADHD affordable and available worldwide as soon as possible," said Leon Ekchian, Ph.D., President & CEO of NeuroSigma.

Background - TNS
The trigeminal nerve is the largest cranial nerve, offering a high-bandwidth pathway for signals to enter the brain.  The trigeminal nerve projects to specific areas of the brain, such as the locus coeruleus, nucleus tractus solitarius, thalamus and the cerebral cortex, which are involved in epilepsy, depression, PTSD, ADHD and other disorders. 

Trigeminal Nerve Stimulation (TNS) is the electrical stimulation of branches of the trigeminal nerve, which are located very close to the surface of the skin in the forehead.  The low-energy stimulus is confined to the soft tissues of the forehead without direct penetration into the brain.  PET imaging studies in humans confirm that eTNS activates or inhibits key regions implicated in these disorders and the changes were observed within minutes of therapy.

NeuroSigma's first TNS product, the Monarch™ eTNS™ System, is currently being marketed to patients in the European Union (EU), with a physician's prescription. In September 2012, NeuroSigma received CE Mark approval for the adjunctive treatment of epilepsy and major depressive disorder, for adults and children 9 years and older in the EU and last month received a Class 2 medical device license from Health Canada covering the use of the system in adults and children 9 years and older for treatm
'/>"/>

SOURCE NeuroSigma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
2. Positive Clinical Study Results for BSPs HyperQ Technology
3. Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes
4. Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office
5. Metabolex Announces Positive Results From its Clinical Study of Arhalofenate in Combination With Febuxostat
6. Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
7. Silence Therapeutics Announces Positive Response by USPTO that Affirms Validity of Four Foundational RNAi Patents
8. Idenix Reports Positive Interim Data for HCV Nucleotide Inhibitor, IDX184
9. Xention Reports Positive Phase 1 Data for New Atrial Fibrillation Drug
10. Echo Therapeutics to Present Positive Clinical Trial Results at the 72nd Scientific Sessions of the American Diabetes Association
11. Syndax Pharmaceuticals Announces Start of Phase 1/2 Study of Entinostat in Combination with Lapatinib in HER2-Positive Metastatic Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 This webinar ... on nonclinical and clinical safety assessment in biosimilars. ... guide a path for biosimilar drug development, however ... of biosimilarity with regards to quality, safety and ... of biosimilar drug development and registration, development strategies ...
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 ... an enhancement to its Online Web Portal for Life ... now have the ability to specify the subject matter ... nearly 50 life science sub-domains. This will help reduce ... and scientific fields, and decrease the likelihood of error. ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 ... – 11 p.m. , Location: Warrington Country Club, 1360 ... Hepatitis B Foundation, the only national nonprofit organization solely ... improving the quality of life for those affected worldwide, ... 11 at Warrington Country Club in Warrington, Pa. ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... week, I gave you my predictions for the coming year ... few of these predictions come true, 2007 is going to ... Lamis , founder of Singularity University , a community ... worried. Second Life becomes a credible next-generation platform ...
... Wis. - To find out whether radio frequency ... blood banking process, the RFID Lab at the ... banks and multiple vendor partners on what is being called ... at RFID's potential role from donation to transfusion, involves the ...
... Inc. , has announced it will price a forthcoming ... at $3.75 per share. , ,Proceeds from the ... 2006, will be used to support research and development ... and intellectual property protection. The Madison-based company, which has ...
Cached Biology Technology:Reader predictions would make 2007 quite a year 2Reader predictions would make 2007 quite a year 3Reader predictions would make 2007 quite a year 4Reader predictions would make 2007 quite a year 5RFID pilot project aims to improve blood banks 2RFID pilot project aims to improve blood banks 3
(Date:4/15/2014)... University of Missouri researchers have previously shown that a ... exercise exists. In a new study, Frank Booth, a ... found a potential link between the genetic pre-disposition for ... which mental maturation occurs. , For his study, Booth ... activity or extreme laziness. Booth then put the rats ...
(Date:4/15/2014)... has developed over the course of evolution, scientists from ... insights from the study of earwigs. "Young earwig offspring ... what is available amongst themselves, especially when the mother ... Biology section of the Institute of Zoology at Johannes ... from Mainz University and the University of Basel investigated ...
(Date:4/15/2014)... chemotherapy drugs in nanoparticle form could help reduce side ... In recent years, scientists have developed nanoparticles that deliver ... been difficult to design particles that can carry any ... MIT chemists have devised a new way to build ... or more different drugs. In a paper published in ...
Breaking Biology News(10 mins):Genetic pre-disposition toward exercise and mental development may be linked 2Sibling cooperation in earwig families gives clues to early evolution of social behavior 2Targeting cancer with a triple threat 2Targeting cancer with a triple threat 3
... Ohio Supercomputer Center have received a four-year, $1.675 million ... government leaders and the public can use to study ... Researchers will develop a computational system called the ... which models the national power grid. The ICS-EPP will ...
... for Cancer Research congratulates 12 of its members on their ... 65 new members and five foreign associates. Considered ... medicine, the award recognizes individuals who have demonstrated outstanding professional ... and medicine. "This is a great day for ...
... Grant from the American Cancer Society acknowledges the potential ... Ligon is investigating interactions between cells as breast cancer ... out how cancerous and non-cancerous cells communicate with each ... the consequences of those interactions are," Ligon said. ...
Cached Biology News:NSF grant to study national energy policy and technology impacts 2The AACR congratulates its members elected to the Institute of Medicine 2Rensselaer researcher wins prestigious American Cancer Society award for work on cancer 2Rensselaer researcher wins prestigious American Cancer Society award for work on cancer 3